|
|
 |
 |
Zosano Pharma has a strong platform of both technology and product specific Intellectual Property. Zosano has secured 15 specific patent families and 42 patents pending. We continue to build our patent estate on a global basis. |
| Selected Publications |
Effect of delivery parameters on immunization to ovalbumin
following intracutaneous administration by a coated
microneedle array patch system
Georg Widera, Juanita Johnson, Lomi Kim, Luz Libiran, Kofi Nyam,
Peter E. Daddona, Michel Cormier
, Vaccine 24, 1653-1664, 2006 |
Transdermal delivery of desmopressin using a coated microneedle array patch system
Michel Cormier, Bonny Johnson, Mamoud Ameri, Kofi Nyam, Luz Libiran, Dee Dee Zhang and Pete Daddona, Journal of Controlled Release, 97, 503-511, 2004 |
Transdermal delivery of Antisense Oligonucleotides
WeiQi Lin, Michel Cormier, and Peter E. Daddona, Celluar Drug Delivery: Principles and Practice, Humana Press, 227-285 |
Transdermal Drug Delivery
Brad Phipps, Michel Cormier, Bob Gale, Bill van Osdal, Jay Audett, Rama Padmanabhan and Peter Daddona, Encyclopedia of Biomaterials and Biomedical Engineering, Marcel Dekker, Inc. New York, 1677-1689, 2004 |
Macroflux® Transdermal Technology Development for the Delivery of Therapeutic Peptides & Proteins
Pete Daddona, PhD, Drug Delivery Technology 2, 54-57, 2002 |
Macroflux® Microprojection Array Patch Technology: A New and Efficient Approach for Intracutaneous Immunization
James A. Matriano, Michel Cormier, Juanita Johnson, Wendy A. Young, Margaret Buttery, Kofi Nyam, and Peter E. Daddona, Pharmaceutical Research, Vol 19, 63-70, 2002
|
Macroflux® Technology for Transdermal Delivery of Therapeutic Proteins and Vaccines
Michel Cormier and Peter E Daddona
, Modified-Release Drug Delivery Technology, Marcel Dekker, Inc. New York, 589-598, 2002 |
Transdermal delivery of Antisense Oligonucleotides with Microprojection Patch (Macroflux®) Technology
WeiQi Lin, Michel Cormier, Amad Samiee, Angie Griffin, Bonny Johnson, Ching-Leou Teng, Gregory E. Hardee and Peter E. Daddona
, Pharmaceutical Research, 19, 1789-1793, 2001 |
| |
|
|